Listed companies of the HDFC group include HDFC Limited, HDFC Bank Limited, HDFC Standard Life Insurance Company Limited ... In March 2011, HDFC Debt Fund for Cancer Cure was launched.

As of 3:16:04 PM GMT+5:30. Market Open. HDFC Life Insurance Co Ltd (NSE:HDFCLIFE) reports robust growth in individual WRP and market share, while addressing margin pressures and regulatory impacts.

HDFC Life Insurance Company Limited is formed as a Joint Venture between Housing Development Finance Corporation Limited (HDFC Limited) and Abrdn plc, formerly Standard Life Aberdeen plc.

ABOUT HDFC LIFE INSUR. HDFC Life Insurance Company, also known as HDFC Life, is among India’s leading life insurance providers. HDFC Life is headquartered in Mumbai, Maharashtra. The company is ...

Globally, tobacco use is a leading cause of cancer-related deaths. (Image Credits: Pixabay) A new study has revealed how smoking damages DNA could open new possibilities for targeted cancer ...

HDFC Life, one of India's leading life insurers, is proud to announce that it has been awarded the Silver Shield in ...

Out-of-pocket costs like deductibles and copays deter people with cancer from complying with treatment.This creates a ...

One in two people will develop some form of cancer during their lifetime, sparking fear and anxiety. A cancer diagnosis can be life-changing and leads people to seek out potential triggers.

There is no assurance that the investment objective of the Scheme will be realized. The HDFC Flexi Cap Fund Growth has an AUM of 65966.82 crores & has delivered CAGR of 22.10% in the last 5 years.

For all investors looking to unearth stocks that are poised to move. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol ...

Powerful mix of both trader and investor packs with timely expert advice. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

Feb. 19, 2025 — Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could ...